Skip to content
OpenCapital
Get started

OnKure Therapeutics, Inc. OKUR Deferred Compensation Liability (Non-Current)

Deferred Compensation Liability (Non-Current) at other companies

Lantheus Holdings logo
Lantheus HoldingsLNTH
$1.75M+192%
OFL
Omega FlexOFLX
$475K+50.8%
Hooker Furnishings Corporation logo
Hooker Furnishings CorporationHOFT
$6.15M-7.5%
Trueblue logo
TrueblueTBI
$35.44M-4.0%
Cross Country Healthcare logo
Cross Country HealthcareCCRN
$2.24M—
The RMR Group logo
The RMR GroupRMR
$9.79M+73.2%

Other financials

Income statement

See full
Revenue-—
Operating income-$15.6M+8.1%
Net income-$15.2M+4.8%
EPS (diluted)-$1.11+6.7%

Balance sheet

See full
Cash & equivalents$192.1M+98.7%
Total debt$409.0K-57.2%
Total equity$184.4M+103%
Total assets$198.7M+98.9%

Cash flow

See full
Operating cash flow-$12.9M+7.6%
CapEx$5.0K-72.2%
Free cash flow-$12.9M+7.7%

Valuation

See full
Market cap$184.2M+72.6%
Enterprise value-$7.49M-127%

Returns & leverage

See full
Return on equity-42.7%—
Debt / equity0×0.0×
Current ratio13.8×+2.6×

Where this comes from

Reported directly by OnKure Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed November 7, 2024, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s deferred compensation liability (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s deferred compensation liability (non-current)?
OnKure Therapeutics, Inc. (OKUR) reported deferred compensation liability (non-current) of $0 in Q3 2024.
How has OnKure Therapeutics, Inc.'s deferred compensation liability (non-current) changed year-over-year?
OnKure Therapeutics, Inc.'s deferred compensation liability (non-current) decreased by 100.0% year-over-year, from $1.07M to $0.
What is the long-term trend for OnKure Therapeutics, Inc.'s deferred compensation liability (non-current)?
Over 2 years (2021 to 2023), OnKure Therapeutics, Inc.'s deferred compensation liability (non-current) has grown at a -87.4% compound annual growth rate (CAGR), from $444K to $7K.